Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,267 | $3,118 | $2,975 |
| - Cash | $279 | $267 | $442 | $287 |
| + Debt | $172 | $388 | $363 | $351 |
| Enterprise Value | – | $3,389 | $3,039 | $3,039 |
| Revenue | $272 | $255 | $195 | $187 |
| % Growth | 6.8% | 30.8% | 4.6% | – |
| Gross Profit | $157 | $157 | $124 | $113 |
| % Margin | 57.7% | 61.6% | 63.4% | 60.4% |
| EBITDA | -$33 | -$114 | -$89 | $52 |
| % Margin | -12.2% | -44.6% | -45.6% | 28.1% |
| Net Income | -$40 | -$125 | -$101 | $26 |
| % Margin | -14.6% | -49.2% | -51.7% | 14.1% |
| EPS Diluted | -0.44 | -1.36 | -1.1 | 0.28 |
| % Growth | 67.6% | -23.6% | -492.9% | – |
| Operating Cash Flow | $29 | -$13 | -$104 | -$82 |
| Capital Expenditures | -$5 | -$9 | -$2 | -$2 |
| Free Cash Flow | $24 | -$22 | -$106 | -$84 |